CD34 and acute myeloid leukemia: For example, iadademstat (ORY-1001), a covalent and highly specific LSD1 inhibitor, induced a gene-specific increase of H3K4me2, resulting in induction of AML blast differentiation and reduction of LSC self-renewal capacity, while sparing normal CD34-positive cells (47).